Exenatide in adolescent patients with type 2 diabetes: Pharmacokinetics, pharmacodynamics, safety, and

被引:0
|
作者
Malloy, Jaret
Guan, Xuesong
Kothare, Prajakti.
Capparelli, Edmund
Fineman, Mark
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A145 / A145
页数:1
相关论文
共 50 条
  • [41] Pharmacodynamics and pharmacokinetics of intravenous glibenclamide in Caucasian and Chinese patients with type-2 diabetes
    A. Jönsson
    J. C. N. Chan
    T. Rydberg
    S. Vaaler
    B. Hallengren
    C. S. Cockram
    J. A. J. H Critchley
    A. Melander
    European Journal of Clinical Pharmacology, 2000, 55 : 721 - 727
  • [42] Pharmacodynamics and pharmacokinetics of intravenous glibenclamide in Caucasian and Chinese patients with type-2 diabetes
    Jönsson, A
    Chan, JCN
    Rydberg, T
    Vaaler, S
    Hallengren, B
    Cockram, CS
    Critchley, JAJH
    Melander, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 55 (10) : 721 - 727
  • [43] Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics
    Jacobsen, Lisbeth V.
    Flint, Anne
    Olsen, Anette K.
    Ingwersen, Steen H.
    CLINICAL PHARMACOKINETICS, 2016, 55 (06) : 657 - 672
  • [44] Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics
    Lisbeth V. Jacobsen
    Anne Flint
    Anette K. Olsen
    Steen H. Ingwersen
    Clinical Pharmacokinetics, 2016, 55 : 657 - 672
  • [45] Pharmacokinetics and pharmacodynamics of the rapid-acting analogue insulin Aspart in pediatric/adolescent patients with type I diabetes
    Olsen, B
    Lindholm, A
    Mortensen, H
    Hylleberg, B
    PEDIATRIC RESEARCH, 2000, 47 (04) : 136A - 136A
  • [46] Pharmacokinetics, safety, and tolerability of single- and multiple-dose exenatide once weekly in Chinese patients with type 2 diabetes mellitus
    Cui, Yi Min
    Guo, Xiao Hui
    Zhang, Dong Mei
    Tham, Lai San
    Tang, Cheng Cai
    Mace, Kenneth
    Linnebjerg, Helle
    JOURNAL OF DIABETES, 2013, 5 (02) : 127 - 135
  • [47] A randomized clinical trial to evaluate the single-dose pharmacokinetics, pharmacodynamics, and safety of sitagliptin in pediatric patients with type 2 diabetes
    Fraser, Iain P.
    Neufeld, Naomi D.
    Fox, Larry A.
    Kipnes, Mark S.
    Miller, Tracie L.
    Zeitler, Philip S.
    Rodriguez, Henry
    Gilmartin, Jocelyn H.
    Lee, Susan J.
    Patterson, Jaclyn K.
    Li, Xiujiang S.
    Maganti, Lata
    Luo, Wen-Lin
    Tatosian, Daniel A.
    Stoch, S. Aubrey
    PEDIATRIC DIABETES, 2019, 20 (01) : 48 - 56
  • [48] Safety, Pharmacokinetics and Pharmacodynamics of Albiglutide in Japanese Subjects with Type 2 Diabetes: A Phase I/II Study
    Seino, Yutaka
    Nakajima, Hiromu
    Miyahara, Hajime
    Kurita, Takashi
    Bush, Mark A.
    Yang, Fred
    Stewart, Murray W.
    DIABETES, 2009, 58 : A156 - A157
  • [49] A phase I/II study of the safety, pharmacokinetics and pharmacodynamics of albiglutide in Japanese subjects with type 2 diabetes
    Bush, M. A.
    Nakajima, H.
    Miyahara, H.
    Kurita, T.
    Yang, F.
    Stewart, M. W.
    Seino, Y.
    DIABETOLOGIA, 2009, 52 : S291 - S291
  • [50] Safety and Tolerability of Exenatide Once Weekly in Patients With Type 2 Diabetes: An Integrated Analysis of 4328 Patients
    Macconell, Leigh
    Gurney, Kate
    Malloy, Jaret
    Zhang, H.
    Zhou, Ming
    Chen, Steve
    DIABETES, 2012, 61 : A598 - A598